Evidence map›Paper›PMID 35260165›Full record

ArticleBMC biology2022

Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level.

Charles Dussiau, Agathe Boussaroque, Mathilde Gaillard, Clotilde Bravetti, Laila Zaroili, Camille Knosp, Chloé Friedrich, Philippe Asquier, Lise Willems, Laurent Quint and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Advancements in the Application of scRNA-Seq in Breast Research: A Review.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Charles DussiauInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Agathe BoussaroqueInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Mathilde GaillardENS de Lyon, Université Claude Bernard, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, Université de Lyon, 46 allée d'Italie Site Jacques Monod, F-69007, Lyon, France.
Clotilde BravettiInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Laila ZaroiliInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Camille KnospInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Chloé FriedrichInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Philippe AsquierPole Sante Leonard de Vinci, Chambray Les Tours, France.
Lise WillemsAssistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Clinique, Hôpital Cochin, Paris, France.
Laurent QuintAssistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Clinique, Hôpital Cochin, Paris, France.
Didier BouscaryInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Michaela FontenayInstitut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France.
Thibault EspinasseUniversité Lyon 1, CNRS UMR5208, Institut Camille Jordan, Université de Lyon, 43 blvd. du 11 novembre 1918, F-69622, Villeurbanne Cedex, France.
Adriana PlesaHospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Pierre-Bénite, France.
Pierre Sujobert *Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Pierre-Bénite, France.
Olivier Gandrillon *ENS de Lyon, Université Claude Bernard, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, Université de Lyon, 46 allée d'Italie Site Jacques Monod, F-69007, Lyon, France.
Olivier Kosmider *Institut Cochin, CNRSUMR8104, INSERM U1016, OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Université de Paris, Paris, France. olivier.kosmider@inserm.fr.ORCID 0000-0002-6021-4057
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRHôpital américain de paris · FRPôle Léonard de Vinci · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMature blood cells arise from hematopoietic stem cells in the bone marrow by a process of differentiation along one of several different lineage trajectories. This is often represented as a series of discrete steps of increasing progenitor cell commitment to a given lineage, but as for differentiation in general, whether the process is instructive or stochastic remains controversial. Here, we examine this question by analyzing single-cell transcriptomic data from human bone marrow cells, assessing cell-to-cell variability along the trajectories of hematopoietic differentiation into four different types of mature blood cells. The instructive model predicts that cells will be following the same sequence of instructions and that there will be minimal variability of gene expression between them throughout the process, while the stochastic model predicts a role for cell-to-cell variability when lineage commitments are being made.

resultsApplying Shannon entropy to measure cell-to-cell variability among human hematopoietic bone marrow cells at the same stage of differentiation, we observed a transient peak of gene expression variability occurring at characteristic points in all hematopoietic differentiation pathways. Strikingly, the genes whose cell-to-cell variation of expression fluctuated the most over the course of a given differentiation trajectory are pathway-specific genes, whereas genes which showed the greatest variation of mean expression are common to all pathways. Finally, we showed that the level of cell-to-cell variation is increased in the most immature compartment of hematopoiesis in myelodysplastic syndromes.

conclusionsThese data suggest that human hematopoietic differentiation could be better conceptualized as a dynamical stochastic process with a transient stage of cellular indetermination, and strongly support the stochastic view of differentiation. They also highlight the need to consider the role of stochastic gene expression in complex physiological processes and pathologies such as cancers, paving the way for possible noise-based therapies through epigenetic regulation.

Indexed as

Epigenesis, GeneticHematopoiesisCell DifferentiationEntropyHematopoietic Stem CellsHumansCell-to-cell variabilityEntropyHematopoiesisMyelodysplastic syndromesSingle-cell RNA-seq

Identifiers

PMID35260165
PMCPMC8905725
OpenAlexW4220894429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.